Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
8.11
+0.17 (2.17%)
Sep 22, 2026, 1:00 PM EDT - Market open
Cartesian Therapeutics Employees
Cartesian Therapeutics had 75 employees as of December 31, 2025. The number of employees increased by 9 or 13.64% compared to the previous year.
Employees
75
Change (1Y)
9
Growth (1Y)
13.64%
Revenue / Employee
$19,693
Profits / Employee
-$2,025,213
Market Cap
245.43M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 75 | 9 | 13.64% | 75 | 0 |
| Dec 31, 2024 | 66 | 28 | 73.68% | 66 | 0 |
| Dec 31, 2023 | 38 | - | - | 37 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| ProQR Therapeutics | 187 |
| Entrada Therapeutics | 152 |
| Sutro Biopharma | 128 |
| AC Immune | 122 |
| Foghorn Therapeutics | 106 |
| Lineage Cell Therapeutics | 77 |
| Compugen | 75 |
RNAC News
- 14 days ago - Cartesian Therapeutics Announces New Employment Inducement Grants - GlobeNewsWire
- 19 days ago - Cartesian Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Cartesian Therapeutics Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Cartesian Therapeutics Earnings release: Q2 2026 - Filings
- 3 months ago - Cartesian Therapeutics Announces New Employment Inducement Grant - GlobeNewsWire
- 3 months ago - Cartesian Therapeutics Transcript: AGM 2026 - Transcripts
- 3 months ago - Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases - GlobeNewsWire